Pemphigus

Active Research Protocols

  1. 13-I-0082 – Rituximab (Anti-CD20) for the Treatment of Subjects With Anticytokine Autoantibody-Associated Diseases
NOTE: PDF documents require the free
Adobe Reader.
This page was last updated: January 24, 2014